Ribociclib effective in HR+, HER2– breast cancer

Ribociclib effective in HR+, HER2– breast cancerRibociclib effective in HR⁺, HER2^– breast cancer, Published online: 21 June 2018; doi:10.1038/s41571-018-0059-2Ribociclib effective in HR+, HER2– breast cancer

Source: Nature Clinical Practice Oncology - June 21, 2018 Category: Cancer & Oncology Authors: Peter Sidaway Source Type: research